Neuralstem to Participate at Upcoming Investor Conferences

GERMANTOWN, Md., Mar. 12 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that members of the management team will participate at the following upcoming investor conferences:   B. Riley FBR, Inc. & Co. China Healthcare Investment & Partnering Symposium in Hangzhou, China, on Saturday, March [...]